New! Rigvir SE
The world's
first food supplement with a live virus.
An effective way to prevent cancer. Order Now!
Information center
info@virotherapy.com
+1 202 769 5306 
Rigvir guidelines have been published
Following Good Pharmaceutical Practice, International Virotherapy Center has published the guidelines for the use of Rigvir in oncology to further educate patients and promote their personal responsibility for their health, as well as to improve patient interactions with healthcare professionals.
Rigvir Virus in Webshop!
Rigvir virus is freely available for purchase on the web shop under the new brand name ECHO-7 RIGVIR. The owner of the analogue Rigvir is ‘AramaPharm, Ltd,’ which received a license from the Rigvir group. ECHO-7 RIGVIR, like the original Rigvir, is produced under GMP conditions; its safety, quality, sterility, and tests do not change. The Rigvir group provides analog product quality monitoring and supervision in the market.
Cancer patients and their loved ones are welcome to watch the famous documentary “The Truth About Cancer”. Pay special attention to the third episode, where doctors and patients discuss the remarkable results of the Rigvir virus. Please follow this link www.thetruthaboutcancer.tv to watch the movie.
Food supplement Rigvir SE for cancer prevention
We invite people with increased cancer risks or positive tumour markers to order Rigvir SE now on www.smartnanovirus.com
WATCH MOVIE NOW!INFORMATION CENTER
Our support agents are here to answer your questions at any time. You can either e-mail us at info@virotherapy.com or leave your query on the website and we will contact you.
FIND OUT IF VIROTHERAPY CAN HELP YOU
RECENT CLINICAL PUBLICATIONS
4-Week repeated dose rat GLP toxicity study of oncolytic ECHO-7 virus Rigvir administered intramuscularly with a 4-week recovery period
Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir® therapy: A case report
Adrenal Gland and Gastric Malignant Melanoma without Evidence of Skin Lesion Treated with the Oncolytic Virus Rigvir
ECHO-7 oncolytic virus Rigvir® in an adjuvant setting for stage I uveal melanoma; A retrospective case report
Combination treatment with nivolumab and Rigvir of a progressive stage IIC skin melanoma patient.
A Case of Stage IV Chromophobe Renal Cell Carcinoma Treated with the Oncolytic ECHO-7 Virus, Rigvir®
Oncolytic viruses are a fast-developing cancer treatment field. Numerous viruses have been tested in clinical trials and three are approved. The first, Rigvir, is an immunomodulator with anti-tumour effect
Multimodality Treatment of a Colorectal Cancer Stage IV Patient with FOLFOX-4, Bevacizumab, Rigvir Oncolytic Virus, and Surgery
Effect of the oncolytic ECHO-7 virus Rigvir® on the viability of cell lines of human origin in vitro
Melanoma Unknown Primary Brain Metastasis Treatment with ECHO-7 Oncolytic Virus Rigvir: A Case Report
Long-term treatment with the oncolytic ECHO-7 virus Rigvir of a melanoma stage IV M1c patient, a small cell lung cancer stage IIIA patient, and a histiocytic sarcoma stage IV patient-three case reports
Adapted ECHO-7 virus Rigvir immunotherapy (oncolytic virotherapy) prolongs survival in melanoma patients after surgical excision of the tumor in a retrospective study
MORE VIDEOS
How does Oncolytic Virotherapy works?
About International Virotherapy Center
Oncolytic virus effect on the circulating tumor cells and prevention of metastases
)
© 2024 International Virotherapy Center Limited. All Rights Reserved